131 related articles for article (PubMed ID: 8710758)
1. Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in rats.
Yeh TK; Kang HJ; Wientjes MG; Au JL
Pharm Res; 1996 Apr; 13(4):628-32. PubMed ID: 8710758
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine.
Kang HJ; Wientjes MG; Au JL
Pharm Res; 1997 Mar; 14(3):337-44. PubMed ID: 9098877
[TBL] [Abstract][Full Text] [Related]
3. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
Gallicano KD; Buttar HS; Moffatt JH
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920
[TBL] [Abstract][Full Text] [Related]
4. Nonlinear disposition of intravenous 2',3'-dideoxyinosine in rats.
Wientjes MG; Mukherji E; Au JL
Pharm Res; 1992 Aug; 9(8):1070-5. PubMed ID: 1409380
[TBL] [Abstract][Full Text] [Related]
5. Tissue pharmacokinetics of 2',3'-dideoxyinosine in rats.
Kang HJ; Wientjes MG; Au JL
Biochem Pharmacol; 1994 Nov; 48(11):2109-16. PubMed ID: 7802702
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II: Effect of 2',3'-dideoxyinosine (ddI) on zidovudine kinetics in monkeys.
Gallo JM; Finco TS; Swagler AR; Mehta MU; Viswanathan CT; Qian M
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):277-83. PubMed ID: 1540413
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat.
Ray GF; Mason WD; Badr MZ
Drug Metab Dispos; 1990; 18(5):654-8. PubMed ID: 1981715
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tissular disposition of pentamidine mesylate in the rat after aerosol or parenteral administration.
Farinotti R; Pascaud MB; Girard PM; Guillot E; Certain A; Trouvin JH
J Infect Dis; 1989 Sep; 160(3):507-12. PubMed ID: 2760501
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid tissues targeting of liposome-encapsulated 2',3'-dideoxyinosine.
Harvie P; Désormeaux A; Gagné N; Tremblay M; Poulin L; Beauchamp D; Bergeron MG
AIDS; 1995 Jul; 9(7):701-7. PubMed ID: 7546414
[TBL] [Abstract][Full Text] [Related]
10. Intracellular activation and cytotoxicity of three different combinations of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
Palmer S; Cox S
AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1227-33. PubMed ID: 8573379
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous absorption of 2',3'-dideoxyinosine in rats.
Mukherji E; Millenbaugh NJ; Au JL
Pharm Res; 1994 Jun; 11(6):809-15. PubMed ID: 7937518
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.
Knupp CA; Brater DC; Relue J; Barbhaiya RH
J Clin Pharmacol; 1993 Oct; 33(10):912-7. PubMed ID: 8227460
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs.
Kaul S; Knupp CA; Dandekar KA; Pittman KA; Barbhaiya RH
Antimicrob Agents Chemother; 1991 Apr; 35(4):610-4. PubMed ID: 1906259
[TBL] [Abstract][Full Text] [Related]
14. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
Singhal D; Morgan ME; Anderson BD
Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
[TBL] [Abstract][Full Text] [Related]
15. Extensive absorption of 2',3'-dideoxyinosine by intratracheal administration in rats.
Gao X; Wientjes MG; Au JL
Pharm Res; 1995 Dec; 12(12):1901-6. PubMed ID: 8786964
[TBL] [Abstract][Full Text] [Related]
16. Disposition of intravenous 123iodopentamidine in man.
Thomas SH; Page CJ; Blower PJ; Chowienczyk P; Ward A; Kamali F; Bradbeer CS; Bateman NT; O'Doherty MJ
Nucl Med Biol; 1997 May; 24(4):327-32. PubMed ID: 9257331
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
Anderson BD; Morgan ME; Singhal D
Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823
[TBL] [Abstract][Full Text] [Related]
18. Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
Hoesterey BL; Galinsky RE; Anderson BD
Drug Metab Dispos; 1991; 19(5):907-12. PubMed ID: 1686234
[TBL] [Abstract][Full Text] [Related]
19. Immunotoxicity of 2',3'-dideoxyinosine in female B6C3F1 mice.
Phillips KE; McCay JA; Brown RD; Musgrove DL; Meade BJ; Butterworth LF; Wilson S; White KL; Munson AE
Drug Chem Toxicol; 1997 Aug; 20(3):189-228. PubMed ID: 9292277
[TBL] [Abstract][Full Text] [Related]
20. Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses.
Al-Ghananeem AM; Saeed H; Florence R; Yokel RA; Malkawi AH
J Drug Target; 2010 Jun; 18(5):381-8. PubMed ID: 20001275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
